ARCHIVES

CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution

This article is from The Cancer Letter archive.

Vol. 08 No. 32 | August 20, 1982

Download PDF Visit The Full Archive

Related Articles

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

In Brief: Adjuvant Chemotherapy Standard Practice For Breast Cancer At Milan, Bonadonna Says

May 7, 1976

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998